Top 50 Life Science Startup Investors in France (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bpifrance
VC Fund
|
16 | France, United States, Switzerland | Seed, Series A | Software, Information Technology, Health Care | $694k–$35M |
|
Kurma Partners
VC Fund
|
8 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$95M |
|
Seventure Partners
VC Fund
|
6 | France, United States, Germany | Series A, Series B | Biotechnology, Health Care, Software | $3.1M–$65M |
|
Omnes Capital
VC Fund
|
6 | France, Germany, United States | Series A, Series B | Software, Biotechnology, Health Care | $3.5M–$44M |
|
Sofinnova Partners
VC Fund
|
5 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$120M |
|
Angels Santé
VC Fund
|
4 | France, India, United States | Seed, Angel | Health Care, Biotechnology, Medical Device | $658k–$4.2M |
|
Idinvest Partners
VC Fund
|
4 | France, United States, Spain | Series B, Series A | Biotechnology, Health Care, Software | $3.3M–$66M |
|
Paca Investissement
VC Fund
|
4 | France | Seed, Series A | Software, Internet, Manufacturing | $329k–$9.2M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
AdBio partners
VC Fund
|
3 | France, Spain, Belgium | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $2.2M–$37M |
|
Blue Horizon Corporation
VC Fund
|
3 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $450k–$28M |
|
Galia Gestion
VC Fund
|
3 | France, United States | Series A, Seed | Software, Manufacturing, Biotechnology | $531k–$6.9M |
|
Karista
VC Fund
|
3 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $713k–$43M |
|
Horizons Ventures
VC Fund
|
2 | United States, United Kingdom, Canada | Series A, Series B, Seed | Biotechnology, Software, Artificial Intelligence | $1M–$110M |
|
Sofimac Investment Managers
VC Fund
|
2 | France, Italy, Austria | Seed, Series A | Biotechnology, Health Care, Manufacturing | $274k–$15M |
|
Advent Life Sciences
VC Fund
|
2 | United States, United Kingdom, France | Series A, Series B | Biotechnology, Health Care, Medical | $5.5M–$75M |
|
Point Nine
VC Fund
|
2 | Germany, United States, France | Seed, Series A, Series B | Software, SaaS, Internet | $900k–$53M |
|
IRDI SORIDEC Gestion
VC Fund
|
2 | France, Brazil, Singapore | Seed, Series A | Software, Biotechnology, Medical | $1.6M–$13M |
|
Lundbeckfonden Ventures
VC Fund
|
2 | United States, Denmark, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $10M–$95M |
|
Alexandria Venture Investments
VC Fund
|
2 | United States, Canada, France | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$150M |
|
JDRF T1D Fund
VC Fund
|
2 | United States, Canada, France | Series A, Series B | Biotechnology, Health Care, Medical | $7M–$130M |
|
Andrew Nutter
Angel
|
2 | France, United Kingdom, United States | Seed, Pre-Seed | Software, SaaS, FinTech | $550k–$4.9M |
|
Heartcore Capital
VC Fund
|
2 | Denmark, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, FinTech | $1.3M–$76M |
|
WiSEED
VC Fund
|
2 | France, Norway | Seed, Equity Crowdfunding | Software, Biotechnology, Manufacturing | $384k–$3.3M |
|
Eutopia VC
VC Fund
|
2 | France, Belgium, Denmark | Seed, Series A | Retail, E-Commerce, Food and Beverage | $11M–$53M |
|
Social Starts
VC Fund
|
2 | United States, Germany, United Kingdom | Seed, Series A | Software, Health Care, Artificial Intelligence | $100k–$15M |
|
Kinled Holding
VC Fund
|
2 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | |
|
Air Street Capital
VC Fund
|
2 | United States, United Kingdom, France | Seed, Series A, Series B | Artificial Intelligence, Software, Biotechnology | $2.6M–$300M |
|
Invus
VC Fund
|
2 | United States, France, China | Series B, Series C, Series A | Biotechnology, Health Care, Therapeutics | $14M–$250M |
|
Thia Ventures
VC Fund
|
2 | United States, France, Denmark | Series A, Seed, Series B | Biotechnology, Health Care, Food and Beverage | $3.3M–$53M |
|
AQUITI Gestion
VC Fund
|
2 | France, United States | Series A, Seed | Software, Biotechnology, Manufacturing | $170k–$18M |
|
Polytechnique Ventures
VC Fund
|
2 | France, United Kingdom, United States | Seed, Series A | Biotechnology, Robotics, Information Technology | $2.1M–$17M |
|
Siparex Groupe
VC Fund
|
2 | France, United States, Italy | Private Equity, Seed | Manufacturing, Software, Electronics | $658k–$31M |
|
Partech
VC Fund
|
2 | United States, France, Germany | Series A, Seed, Series B | Software, E-Commerce, SaaS | $1.1M–$55M |
|
Sylvain Zimmer
Angel
|
2 | France, United States, United Kingdom | Seed, Pre-Seed, Angel | Software, SaaS, Food and Beverage | $200k–$10M |
|
Beyond Impact
VC Fund
|
2 | France, Canada, Singapore | Seed, Series A, Pre-Seed | Food and Beverage, News, Seafood | $670k–$53M |
|
XAnge
VC Fund
|
2 | France, Germany, Belgium | Series A, Seed, Series B | Software, SaaS, E-Commerce | $1.1M–$60M |
|
Sofipaca
VC Fund
|
1 | France | Private Equity, Series A, Series B | Food and Beverage, Pharmaceutical, Manufacturing | |
|
Earlybird Venture Capital
VC Fund
|
1 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Health Care | |
|
Resonance
VC Fund
|
1 | France, United Kingdom, United Arab Emirates | Series A, Pre-Seed, Seed | Software, Information Services, B2C | |
|
Florac
VC Fund
|
1 | France | Series A, Private Equity | Sales, E-Commerce, Health Care | |
|
Bioqube Ventures
VC Fund
|
1 | United States, France, Ireland | Series A, Seed, Series B | Biotechnology, Health Care, Life Science | |
|
Banque Populaire Group
VC Fund
|
1 | France | Seed, Pre-Seed | Manufacturing, Energy, Software | |
|
ACG Management
VC Fund
|
1 | France, Madagascar | Seed, Series A | Software, Health Care, Biotechnology | |
|
IXO Private Equity
VC Fund
|
1 | France, United States, Canada | Private Equity, Series A | Health Care, Manufacturing, Biotechnology | |
|
Banexi Ventures
VC Fund
|
1 | France, United States, United Kingdom | Series B, Series A | Mobile, Internet, Video | |
|
Afone Participations
VC Fund
|
1 | France | Series A | Software, Compliance, Life Science | |
|
Bertrand Jacquelot
Angel
|
1 | France, United States | Pre-Seed, Seed, Angel | E-Commerce, Information Technology, Food and Beverage | |
|
Capital Grand Est
VC Fund
|
1 | France | Seed, Series A | Health Care, Biotechnology, Computer | |
|
Roche Venture Fund
VC Fund
|
1 | United States, United Kingdom, Spain | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | |
| Access all 262 investors in France Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1070
- Round size: Seed $694k–$6.9M; Series A $2.6M–$35M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Melvan — Melvan develops, finances, builds and operates solar and wind installations, combined, where relevant, with storage facilities.
- NewHeat — NewHeat owns and operates solar heat plants. It engages in financing, engineering, procurement, construction, and operation of solar heat plants that transform solar radiation into heat. It uses solar thermal collectors to transfer solar energy to water, steam, or thermal oil.
- Ostrea — OSTREA is a pioneering company in the creation of high-performance materials based on bio-minerals: seashells.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 132
- Round size: Seed $2.3M–$13M; Series A $3.8M–$95M; Series B $8.8M–$80M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 218
- Round size: Series A $3.1M–$24M; Series B $3.3M–$65M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Sentryc — Protect your brand and your products from counterfeiters with Sentryc. We monitor over 120 marketplaces for you and remove potential counterfeits.
- Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Series B
- Geography: France, Germany, United States
Investor stats
- Total investments: 180
- Round size: Series A $3.5M–$44M; Series B $4.4M–$43M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $403M in 2020
Portfolio highlights
- SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
- Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
- Capsule Labs — We create frictionless web3 solutions for widespread adoption / Capsule Corp Labs
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 309
- Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
- l'école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
- EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Angel
- Geography: France, India, United States
Investor stats
- Total investments: 37
- Round size: Seed $1.1M–$4.2M; Angel $658k–$1.3M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
- Odimma — Empowering personalized immunotherapy to treat cancer
- Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A
- Geography: France, United States, Spain
Investor stats
- Total investments: 252
- Round size: Series A $3.3M–$24M; Series B $7.8M–$66M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $88M in 2021
Portfolio highlights
- Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
- Glovo — Glovo delivers the best products of your city in less than 1 hour
- Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.
Show more...Investment focus
- Industry: Software, Internet, Manufacturing
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 73
- Round size: Seed $329k–$1.6M; Series A $411k–$9.2M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
- SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
- C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
- Centauri Therapeutics — At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 31
- Round size: Seed $2.2M–$18M; Series A $19M–$37M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $116M in 2021
Portfolio highlights
- DiogenX — Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment
- AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 94
- Round size: Seed $2M–$12M; Pre-Seed $450k–$6.3M; Series A $2M–$28M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $187M in 2021
Portfolio highlights
- WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
- foodforecast — AI supported solution to reduce food waste.
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more...Investment focus
- Industry: Software, Manufacturing, Biotechnology
- Stage:Series A, Seed
- Geography: France, United States
Investor stats
- Total investments: 55
- Round size: Seed $531k–$2.9M; Series A $849k–$6.9M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $21M in 2013
Portfolio highlights
- Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
- Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 147
- Round size: Seed $713k–$6.6M; Series A $1.2M–$18M; Series B $2.5M–$43M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
- Physikron — Physikron is a developer of mass spectrometry technologies used to improve the performance of tandem spectrometry. Its technologies offer proteomic analysis and dramatically improves the number of peptides and proteins identified during an LC/MS/MS acquisition that enable researchers to research in an enhanced way.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Biotechnology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 250
- Round size: Seed $1M–$11M; Series A $6.2M–$50M; Series B $8M–$110M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
- Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: France, Italy, Austria
Investor stats
- Total investments: 73
- Round size: Seed $274k–$2M; Series A $1.6M–$15M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
- Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
- Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 65
- Round size: Series A $5.5M–$53M; Series B $21M–$75M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- MiroBio — MiroBio's platform is based on ground-breaking research by their scientific founders at the University of Oxford delineating how immune cells communicate and how they are activated. These insights have enabled MiroBio to create antibodies that can leverage natural signalling mechanisms to restore immune system balance and control.
- Acutus Medical — Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists.Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Itsproducts are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.It was founded in 2011 and headquartered in Carlsbad, California.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.
Show more...Investment focus
- Industry: Software, SaaS, Internet
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 255
- Round size: Seed $900k–$7.7M; Series A $3.2M–$24M; Series B $9M–$53M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Athenian — Introducing the world to software engineering metrics that help teams, and improve processes. Athenian is built for GitHub and Jira users.
- Lottielab — Easiest animation editor for design and tech teams.
- Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: France, Brazil, Singapore
Investor stats
- Total investments: 52
- Round size: Seed $1.6M–$5.8M; Series A $3.7M–$13M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
- Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
- DiappyMed — DiappyMed specializes in developing platforms to calculate insulin dosages.
Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 67
- Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $16M–$53M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
- Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 247
- Round size: Seed $2M–$31M; Series A $12M–$100M; Series B $25M–$150M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- miRecule — MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States.
- Marvin Health — Marvin is a mental health service for physicians. We're ending the one-size-fits-all approach to teletherapy, helping you to set a teletherapy action plan.
- Deep Genomics — Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, Canada, France
Investor stats
- Total investments: 55
- Round size: Series A $7M–$105M; Series B $18M–$130M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- IMTherapeutics — Redefining Autoimmunity, Transforming Lives
- vTv Therapeutics — vTv Therapeutics, a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. Its mission is to utilize its innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.vTv Therapeutics has a pipeline of small molecule clinicaland pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation, and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv's product candidate pipeline, platform technology, scientific team, and strategic collaborations have enabled it to become a fully integrated pharmaceutical company.The company's commitment to drug discovery is reflected in its medical solutions and the many exciting potential new treatment options in its pipeline. The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.vTv Therapeutics is advancing several proprietary drug candidates. The company's lead candidate, azeliragon (aka TTP488), is a novel, orally bioavailable small molecule compound that is being developed for the treatment of Alzheimer's disease. In Phase 2 clinical trial in patients with mild to moderate Alzheimer's disease, azeliragon showed a statistically significant difference of more than 3 points in ADAS-cog at 18 months compared to placebo.Azeliragon has been granted Fast Track Designation and agreement on its Phase 3 protocol has been reached with FDA via a Special Protocol Assessment (SPA). The Phase 3 study in patients with mild Alzheimer's disease was initiated in April 2015 with a clear path forward to registration with the aim to demonstrate disease modification.vTv Therapeutics is also prosecuting the clinical development of TTP399, a novel functionally liver-selective Glucokinase Activator ("GKA") for the treatment of type 2 diabetes. In a Phase 2a study, TTP399 normalized patients' HbA1c without inducing hypoglycemia, after only six weeks of treatment. A six-month Phase 2 study is ongoing.
- Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 25
- Round size: Seed $550k–$4.9M; Pre-Seed $809k–$3.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants
- Jump — Jump takes the hassle out of being a freelancer. We accompany hundreds of freelancers in their daily lives by securing their adventure. Relax, we take care of everything.
- Core Biogenesis — Biodesigning the Future of Regenerative Medicine & Skincare
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, Germany
Investor stats
- Total investments: 199
- Round size: Seed $1.3M–$12M; Series A $3.4M–$27M; Series B $9.6M–$76M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- Skynopy — Skynopy offers an end-to-end connectivity solution for satellite operators to communicate with their satellites in Low-Earth Orbit.
- TrapLight Games — A hard-hitting mobile game studio from Finland. Traplight is a premium mobile games studio with 10+ years of game development expertise at the highest level. Our ambition is to create world class, chart topping, scalable game services.
- Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Equity Crowdfunding
- Geography: France, Norway
Investor stats
- Total investments: 30
- Round size: Seed $384k–$3.3M; Equity Crowdfunding $466k–$2.7M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
- Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups
Show more...Investment focus
- Industry: Retail, E-Commerce, Food and Beverage
- Stage:Seed, Series A
- Geography: France, Belgium, Denmark
Investor stats
- Total investments: 15
- Round size: Series A $11M–$53M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
- SPRiNG Collective — SPRiNG is a consumer goods company that offers clean and efficient laundry and cleaning products, delivered in a 100% plastic-free box and directly in the mailbox. The company is headquartered in Paris, Ile-de-France, France by Philippe Cantet, Laure Favre, and Ben Guerville in 2017.
Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 289
- Round size: Seed $100k–$3.7M; Series A $3.2M–$15M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Fulcrum — Designed with technology in mind, be free of paper with Fulcrum, the manufacturing ERP of the future. Ai scheduling, visual BOM, live tracking
- Funnel — Our revolutionary CRM property management software saves both time and money for agents and owners while making leasing more efficient.
- Original Stitch — PLATINUMTOTO hadir sebagai situs togel macau di Indonesia yang sangat populer di kalangan togelers platinumtoto dengan jackpot 4D setiap hari nya
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 114
- Lead/follow: no public data
Portfolio highlights
- Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
- OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
- Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.
Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 44
- Round size: Seed $2.6M–$15M; Series A $5.7M–$33M; Series B $64M–$300M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
- Delian Alliance Industries — Building the digital backbone for the age of autonomous warfare.
- Interloom Technologies — Interloom is the first Navigation System for Work. It helps you map how your teams actually work. Grounded in this precedent, it guides your operational teams with suggested next steps and relevant context and empowers your AI agents to follow their lead.
Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved.They know that real transformation takes time and that it is nevera straight line. They fully align their incentives with their partners and have the wherewithal and long-term commitment to see through any bumps along the way.They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Series A
- Geography: United States, France, China
Investor stats
- Total investments: 255
- Round size: Series A $14M–$200M; Series B $29M–$250M; Series C $30M–$175M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Aive — Turn 1 master into unlimited, brand-controlled versions. Automate post-production, scale your output, and take back control of video performance.
- Thrive Market — High quality organic groceries, delivered to you! Great prices on healthy products and diet-friendly foods from the best brands. Most orders ship free!
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team
Show more...Investment focus
- Industry: Biotechnology, Health Care, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, France, Denmark
Investor stats
- Total investments: 20
- Round size: Seed $3.3M–$20M; Series A $6.3M–$53M; Series B $24M–$50M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
- Clever Carnivore — Clever Carnivore is a cell-cultured meat startup that uses stem cell biology, recombinant protein, and bioengineering to create cost-effective lab grown meats. With the company's high-efficiency model, cruelty-free, environmentally friendly, and cost-competitive technology it aims to produce sausage, burgers, and chicken nuggets.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: France, United States
Investor stats
- Total investments: 57
- Round size: Seed $170k–$4.1M; Series A $849k–$18M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $6.4M in 2010
Portfolio highlights
- Synboli —
- Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
- Amédia Solutions — Amédia Solutions is an IT service provider and telecom operator. It is a local player specializing in B to B IT and telecoms. It has thus been able to forge various strong partnerships with publishers, manufacturers, infrastructure operators, security specialists to offer the best of IT and telecommunications.
Polytechnique Ventures support entrepreneurs from the School's ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Information Technology
- Stage:Seed, Series A
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 22
- Round size: Seed $2.1M–$12M; Series A $7.9M–$17M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Goodvest — Goodvest is an investment app (life insurance) that builds a better world, in line with your values and promoting performance.
- Jimmy — Jimmy is a supplier of carbon-free industrial heat to industrialists. The company designs and markets turnkey thermal generators, connected to the heating circuits of factories. These generators rely on a nuclear micro-reactor to create heat.
- One Biosciences — One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases. Magali Richard, David Schilansky, and Céline Vallot co-founded the company in Paris, Ile-de-France, France.
Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.
Show more...Investment focus
- Industry: Manufacturing, Software, Electronics
- Stage:Private Equity, Seed
- Geography: France, United States, Italy
Investor stats
- Total investments: 122
- Round size: Seed $658k–$6.6M; Private Equity $5.5M–$31M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $500M in 2021
Portfolio highlights
- Cofarco — Cofarco provides finance arrangement, debt transactions, risk management, advisory and credit insurance brokerage services.
- E-Recycle — E-Recycle is an online and offline store that specializes in recycling used high-tech products such as mobile phones, tablets, and PCs.
- Ekoscan Integrity — Ekoscan Integrity is an innovative solution for the integrity and sustainability of industrial products through the implementation of innovative technology.
Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.
Show more...Investment focus
- Industry: Software, E-Commerce, SaaS
- Stage:Series A, Seed, Series B
- Geography: United States, France, Germany
Investor stats
- Total investments: 525
- Round size: Seed $1.1M–$9M; Series A $4.2M–$30M; Series B $9M–$55M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Yampa — Discover yampa's autonomous AI agents and revolutionize your customer experience. Elevate your service with the most advanced AI technology.
- Privitar — Informatica is an Enterprise Cloud Data Management leader that brings data to life by empowering businesses to realize the transformative power of their most critical assets.
- Jaspersoft — Enterprise reporting platform for delivering pixel perfect reports. Build custom reports and dashboards in minutes.
Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.
Show more...Investment focus
- Industry: Software, SaaS, Food and Beverage
- Stage:Seed, Pre-Seed, Angel
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $637k–$10M; Angel $400k–$500k; Pre-Seed $200k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
- TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Beyond Impact is your trusted Managed Service Provider (MSP), delivering tailored IT solutions like managed IT services, cybersecurity, cloud computing, IT help desk support, and data backup. Our expert team aligns your IT with business goals, providing proactive monitoring and network security. Contact us today to streamline your IT operations for a secure, agile, and future-ready business. Beyond Impact: Empowering your IT success.
Show more...Investment focus
- Industry: Food and Beverage, News, Seafood
- Stage:Seed, Series A, Pre-Seed
- Geography: France, Canada, Singapore
Investor stats
- Total investments: 9
- Round size: Seed $670k–$10M; Series A $13M–$53M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Nowadays — The Nowadays nugget is made with just 7 simple, plant-based ingredients.
- SEAFOOD REBOOT — Seafood Reboot's ambition is to promote worldwide best-in-class Fish substitutes from micro-algae for natural, healthy, sustainable food and to preserve marine wildlife.
XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: France, Germany, Belgium
Investor stats
- Total investments: 213
- Round size: Seed $1.1M–$8M; Series A $3M–$20M; Series B $6M–$60M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $234M in 2021
Portfolio highlights
- ELDIM —
- Dattak — Dattak offers cyber insurance solutions based on cybersecurity technologies. Their cybersecurity tools allow us to assess a company's level of cybersecurity without complex questionnaires. They provide their policyholders with a variety of cybersecurity tools to help them prevent and defend against cyberattacks.
- Tomorro — Leeway helps you reduce the time spent on contract management and gives you more control and visibility over legal and financial risks.
Sofipaca supports SMEs and mid-caps in the SOUTH region in the long term in their development capital and transmission capital operations. The company was founded in 1984 and based in Aix en Provence, France.
Show more...Investment focus
- Industry: Food and Beverage, Pharmaceutical, Manufacturing
- Stage:Private Equity, Series A, Series B
- Geography: France
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- HalioDx — Veracyte translates the tumor immune response into clear insights to guide treatment decisions, inform biomarker development, or advance therapeutics.
- Cintoo — Cintoo is essential for BIM to bridge the gap between your physical and virtual worlds.
- Keep Cool — Keep Cool is a operator of a chain of fitness centers.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 308
- Lead/follow: no public data
Portfolio highlights
- SLNG — SLNG is radically global infrastructure for speech AI.
- Voyfai — Voyfai provides a platform to manage shipments, procurement, back-office tasks, and logistics services for freight forwarders.
- Payable — Scale your business with our payment operations API and dashboard. Track, reconcile and make payments instantly.
We are on your frequency - Resonance partners with early-stage founders, helping them to shake up their industry.
Show more...Investment focus
- Industry: Software, Information Services, B2C
- Stage:Series A, Pre-Seed, Seed
- Geography: France, United Kingdom, United Arab Emirates
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
- Tomorro (ex Leeway) — Leeway helps you reduce the time spent on contract management and gives you more control and visibility over legal and financial risks.
- Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Florac is a mid-market investment firm that invests and supports management teams with defensible market-leading positions.It invests in single amounts in equity and quasi-equity with a flexible exit horizon alongside founders, managers, and strategic partners in companies with strong development potential and managed by excellent managementteams. The firm is wholly-owned by the Meyer family and investing only funds of the family.Léopold Meyer headquartered the firm in Paris, Ile-de-France in 2009.
Show more...Investment focus
- Industry: Sales, E-Commerce, Health Care
- Stage:Series A, Private Equity
- Geography: France
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.
- Clubfunding — ClubFunding is a crowdfunding platform. They offer small to medium-sized enterprises assistance in finding alternative financing from assets, individuals, and institutions.
- Bricoprivé.com — Bricoprive.com runs a dozen daily flash sales offering a wide range of professional-quality products to its six million members. On the back of a strong value proposition, unrivalled expertise in sourcing quality products in partnership with suppliers and solid digital experience, the company has evolved to become one of the leaders in the sector.
A life science venture capital fund - investing globally in exciting science to accelerate breakthrough therapies in patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed, Series B
- Geography: United States, France, Ireland
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Enhanc3D Genomics — Enhanc3D Genomics is a spinout company from Babraham Institute.
- SynOx Therapeutics — SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland.
- Bicara Therapeutics — At Bicara, we are attacking cancer head-on by combining the precision of targeted therapies with the power of tumor-microenvironment modulators to create better medicines for patients.
Banque Populaire Group provides banking and credit services for individuals, international and corporate.
Show more...Investment focus
- Industry: Manufacturing, Energy, Software
- Stage:Seed, Pre-Seed
- Geography: France
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- ATAWEY — Founded in 2012 by Jean-Michel Amaré and Pierre-Jean Bonnefond, ATAWEY designs and manufactures turnkey autonomous energy solutions for isolated sites. The entrepreneurs and their teams use mature, tried and tested French technologies to offer you an innovative, reliable and sustainable product. They build on their expertise to give you more than asimple response: a solution that adapts to your uses.The teams are well aware of the importance and the challenges of a source of energy on isolated sites, ATAWEY guarantees you support and a tailor-made service. They take full responsibility for the management of each project for optimal adaptability and reliability, economic relevance with a fast return on investment, all with the greatest respect for the environment.
- Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
- Meccellis Biotech — Meccellis Biotech is a company specializing in acellular dermal matrices and tissue engineering, developing medical devices in La Rochelle.
Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: France, Madagascar
Investor stats
- Total investments: 49
- Lead/follow: no public data
Portfolio highlights
- Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
- Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
- My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.
The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Private Equity, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 62
- Lead/follow: no public data
Portfolio highlights
- F-Reg — F-Reg autonomous and intelligent hydraulic valves are designed to regulate and control flow patterns in sanitation networks. F-Reg sells solutions for regulating flow in networks (rainwater or wastewater) that rely on a patented valve that smooths out peaks in wet weather. The F-Reg device is self-contained and does not require power.
- Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
- Farmitoo — Farmitoo is an online purchase of farm equipment directly from manufacturers.
Banexi Ventures Partners invests through venture capital funds, in early stage companies with high growth potential and high technology in 3 different sectors. The company is headquartered in Paris, France.
Show more...Investment focus
- Industry: Mobile, Internet, Video
- Stage:Series B, Series A
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Dolmen — Dolmen is an all-in-one platform to answer your many customer knowledge issues. Dolmen is the SAAS software solution to deploy in physical outlets and in your marketing departments. In local to animate, conquer and retain your customers. Central to enrich your databases and allow your network to communicate autonomously while driving your marketingactions.
- Reevoo — Millions of shoppers use Reevoo to make better buying decisions in their everyday lives. Hundreds of brands all over the world use our solutions to get a better idea of what makes their customers tick.It’s our transparent and independent approach that makes the difference – we believe honest communication between brand and shopper is better forboth.Reevoo was started by Richard Anson, Ben Griffiths and Guy Logan in 2005 to help customers choose what to buy – not just where or when.Today, Reevoo is seen in more than 60 countries and in 30 different languages. We’re relied on by customers around the world to make better decisions, and by brands to connect with their customers.
- Linkfluence — Linkfluence is a consumer insights platform that combines social media data, AI, and human market research expertise to uncover high-value insights..
Afone Participations is a telecommunications and electronic payments company.
Show more...Investment focus
- Industry: Software, Compliance, Life Science
- Stage:Series A
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BMI System — BMI System is a management software editor for the pharmaceutical, medical, and cosmetics industries The company exports its software packages to Europe and America. With the NAYA Compliance application it has established itself as the leading French company for regulatory compliance software for the pharmaceutical industry.
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more...Investment focus
- Industry: E-Commerce, Information Technology, Food and Beverage
- Stage:Pre-Seed, Seed, Angel
- Geography: France, United States
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
- Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
- Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Capital Grand Est is a private equity firm that focuses on supporting businesses. Capital Grand Est was founded in 2012 and was headquartered in Schiltigheim, France.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Computer
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Sounduct — Sounduct is a medical equipment manufacturer.
- Keey Aerogel — Home - Welcome to the homepage of KEEY Aerogel ! Discover our company, our products and our know-how in aerogels.
- Sirfull Technology — Solutions SIRFULL pour le soudage, l'inspection et la maintenance | Welding cloud logiciel soudage | Linspec Cloud logiciel inspection
We are the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 110
- Lead/follow: no public data
Portfolio highlights
- DiogenX — Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Life Science Investor funding in France at a glance
Stats across 156 deals from 262 investors.
Access all 262 investors in France Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 262 investors investing in France Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!